SCOPUS 정보 검색 플랫폼

Neurology

Volumn 77, Issue 6, 2011, Pages 594-595

Making diagnosis of pompe disease at a presymptomatic stage: To treat or not to treat? Clinical/scientific notes

(6) Laloui, K a Wary, C a,b,c Carlier, R Y b,d Hogrel, J Y a,c Caillaud, C e Laforet P f

a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS (France)

b DIF (France)

c SORBONNE UNIVERSITÉ (France)

d RAYMOND POINCARÉ HOSPITAL (France)

e INSERM (France)

f PITIÉ SALPÊTRIÈRE HOSPITAL (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAN 1,4 ALPHA GLUCOSIDASE; LIVER ENZYME; ALPHA GLUCOSIDASE; GLYCOGEN;

ADULT; BASKETBALL; BLOOD ANALYSIS; BLOOD EXAMINATION; CARBON NUCLEAR MAGNETIC RESONANCE; CARDIOMYOPATHY; CASE REPORT; ECHOCARDIOGRAPHY; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; GLYCOGEN STORAGE DISEASE TYPE 2; HUMAN; LUNG FUNCTION TEST; MUSCLE BIOPSY; MYOPATHY; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; WALKING; AGING; ARTICLE; BIOPSY; DISEASE COURSE; EARLY DIAGNOSIS; ENZYME REPLACEMENT; INFANT; MALE; METABOLISM; MUSCLE STRENGTH; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PHYSIOLOGY; SKELETAL MUSCLE;

AGING; ALPHA-GLUCOSIDASES; BIOPSY; DISEASE PROGRESSION; EARLY DIAGNOSIS; ENZYME REPLACEMENT THERAPY; GLYCOGEN; GLYCOGEN STORAGE DISEASE TYPE II; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MUSCLE STRENGTH; MUSCLE, SKELETAL; YOUNG ADULT;

EID: 80053317662 PISSN: 00283878 EISSN: 1526632X Source Type: Journal
DOI: 10.1212/WNL.0b013e318228c0ea Document Type: Note

Times cited : (25)

References (7)

1
- 53449093327
- Lysosomal storage disease 2: Pompe's disease
- van der Ploeg AT, Reuser A J J. Lysosomal storage disease 2: Pompe's disease. Lancet 2008;372:1342-1353.
- (2008) Lancet , vol.372 , pp. 1342-1353
- Van Der Ploeg, A.T.¹ Reuser, A.J.J.²

2
- 33846033132
- Recombinant human acid α-glucosidase: Major clinical benefits in patients with infantile-onset Pompe disease
- Kishnani P, Corzo D, Nicolino M, et al. Recombinant human acid α-glucosidase: major clinical benefits in patients with infantile-onset Pompe disease. Neurology 2007;68:99-109.
- (2007) Neurology , vol.68 , pp. 99-109
- Kishnani, P.¹ Corzo, D.² Nicolino, M.³

3
- 77950963839
- A randomized study of alglucosidase a in late-onset Pompe's disease
- van der Ploeg AT, Clemens PR, Corzo D, et al. A randomized study of alglucosidase a in late-onset Pompe's disease. N Engl J Med 2010;362:1396-1406.
- (2010) N Engl J Med , vol.362 , pp. 1396-1406
- Van Der Ploeg, A.T.¹ Clemens, P.R.² Corzo, D.³

4
- 67649259008
- Enzyme replacement therapy for infantile-onset Pompe disease: Curse or cure?
- Willems J, Petros A, Brierley J. Enzyme replacement therapy for infantile-onset Pompe disease: curse or cure? Neurology 2008;71:380-381.
- (2008) Neurology , vol.71 , pp. 380-381
- Willems, J.¹ Petros, A.² Brierley, J.³

5
- 0041570135
- Evaluation of muscle glycogen content by 13C NMR spectroscopy in adult-onset acid maltase deficiency
- Wary C, Laforet P, Eymard B, et al. Evaluation of muscle glycogen content by 13C NMR spectroscopy in adult-onset acid maltase deficiency. Neuromuscul Disord 2003;13:545-553.
- (2003) Neuromuscul Disord , vol.13 , pp. 545-553
- Wary, C.¹ Laforet, P.² Eymard, B.³

6
- 4143095952
- Glycogen storage disease type II: Enzymatic screening in dried blood spots on filter paper
- Chamoles NA, Niizawa G, Blanco M, Gaggioli D, Casentini C. Glycogen storage disease type II: enzymatic screening in dried blood spots on filter paper. Clin Chim Acta 2004;347:97-102.
- (2004) Clin Chim Acta , vol.347 , pp. 97-102
- Chamoles, N.A.¹ Niizawa, G.² Blanco, M.³ Gaggioli, D.⁴ Casentini, C.⁵

7
- 77954370184
- Newborn screening of lysosomal storage disorders
- Marsden D, Levy H. Newborn screening of lysosomal storage disorders. Clin Chem 2010;56:1071-1079.
- (2010) Clin Chem , vol.56 , pp. 1071-1079
- Marsden, D.¹ Levy, H.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.